Surgery – Radioactive substance applied to body for therapy – Radioactive substance placed within body
Reexamination Certificate
2000-06-22
2002-12-10
Shaver, Kevin (Department: 3736)
Surgery
Radioactive substance applied to body for therapy
Radioactive substance placed within body
C607S088000
Reexamination Certificate
active
06491618
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to an apparatus and method for the destruction of micro-organisms on or within a body cavity of a patient through the use of ionizing radiation.
BACKGROUND OF THE INVENTION
Infections involving the human gastrointestinal tract are extremely common, involving many millions of people on an annual basis. These infections include bacteria, viruses, and fungi, and are responsible for significant illness, morbidity and, in many cases, death. While the invention has utility in destroying microorganisms in various parts of the body, e.g., the stomach, bowel, lungs, peritoneal cavity, urinary tract, etc., it is particularly useful in the treatment of gastrointestinal infections.
It has recently been shown that the most common gastrointestinal infection in the world is due to
Helicobacter pylori
, a bacterial pathogen that infects the stomach and duodenum. In the United States, for example,
Helicobacter pylori
is found in approximately 20% of the adult population. It is a chronic gut infection and, once acquired, is notoriously difficult to cure. Most infectious bacteria can be readily destroyed by the human immune system; however,
Helicobacter pylori
lives in the lumen of the stomach and on the surfaces of the stomach and duodenal cells, making it relatively resistant to a host immune response, even if vigorous. I have, however, taken advantage of its location in the treatment method and apparatus employed in the present invention.
Helicobacter pylori
is typically a silent infection in humans, the majority of the time causing a relatively innocuous gastric inflammation or gastritis. In a significant minority of infected people, however,
Helicobacter pylori
can cause symptomatic gastritis, gastric ulcer, duodenal ulcer, gastric cancer, and gastric lymphoma. The organism is responsible for approximately 90% of all reported duodenal ulcers, 50% of gastric ulcers, 85% of gastric cancer, and virtually 100% of gastric lymphoma. Millions of Americans have symptomatic gastritis due to
Helicobacter pylori
or the much more serious entities noted above.
Helicobacter pylori
is responsible for thousands of deaths in this country due to complicated ulcer disease and cancer, and is considered to be a Class 3 carcinogen by the World Health Organization, in the same class as Benzene and DDT.
The organism is found in all countries in the world, causing the same symptoms, diseases, and deaths, but it is most prevalent in undeveloped countries, presumably due to poor hygiene, contaminated water supplies and crowding. In Peru and other South American countries, for example, the prevalence rate of
Helicobacter pylori
infection approaches 90%.
There is no vaccine available for
Helicobacter pylori
and none is anticipated in the foreseeable future, despite years of intensive effort. The only treatment currently available is prolonged and complicated antibiotic regimens involving three or four expensive antibiotics given over a two-week period. Even using a vigorous antibiotic regimen, however, up to 20% of those treated are not cured of their infection.
The antibiotics used are powerful, sometimes not well tolerated, and can cause nausea, an altered taste sensation and diarrhea. Allergic reactions are not uncommon. In addition to the problems of efficacy and side effects, antibiotic resistance to this organism is growing rapidly. Up to 50% of the Helicobacter isolates are now resistant to one or more of the best antibiotics known to cure the infection. This problem of antibiotic resistance is only expected to grow in the future, leading to worsening disease outcomes and an ever-increasing health expense.
Thus, a great need exists for a new, effective, rapid and well-tolerated cure of
Helicobacter pylori
, a luminal infection of the gut. There also exists a need for a well-tolerated and effective treatment for debilitating or killing microorganisms with as little intrusion as possible in other body cavities, such as the bowel, lungs, peritoneal cavity or urinary tract.
SUMMARY OF THE INVENTION
This invention provides a treatment method and apparatus for debilitating or killing
Helicobacter pylori
or other microorganisms within the body of a patient and is especially suited for treating stomach or duodenal ulcers. The present therapeutic method involves the use of radiation for eliminating pathogenic micro-organisms within or supported upon the lining of a body cavity of a patient, e.g., the stomach. An elongated flexible shaft is provided for insertion into the body in any of various ways selected by the surgeon. It can be placed endoscopically, e.g., through the esophagus, placed surgically, placed laparoscopically or by CAT scan-guided percutaneous insertion. A radiant energy distribution head is provided at the end of the flexible shaft to provide ionizing radiation for destroying microorganisms within the body. Radiant energy, e.g., x-ray, ultraviolet light, beta radiation, gamma radiation, radio waves, microwaves, or infrared energy is then transferred from the head of the instrument to the epithelium around the head of the instrument in an amount sufficient to debilitate or kill the
Helicobacter pylori
or other microorganisms in the lining of the body cavity.
In one preferred form of instrument, the flexible shaft comprises a coaxial cable surrounded by an electrical insulation layer and has the radiant energy distribution head located at its distal end. In a preferred optional form of the invention, a positioning and distending device around the head of the instrument is of sufficient size to contact and expand the walls of the body cavity in which it is placed both in the front of the distribution head as well as on the sides of the distribution head. For example, the head of the instrument can be supported a controlled distance from the wall of the body cavity by an expandable balloon so as to regulate the amount of energy transferred to the microorganisms. The balloon is preferably bonded to a portion of the flexible shaft at a point spaced from the head. The radiation can be x-ray energy, infrared, ultraviolet, radio waves, microwave, beta radiation or gamma radiation. Other forms of radiant energy that can be used for killing or debilitating surface microorganisms will be apparent to those skilled in the art.
These and other more detailed and specific objects of the present invention will be better understood by reference to the following figures and detailed description which illustrate by way of example of but a few of the various forms of the invention within the scope of the appended claims.
REFERENCES:
patent: 2173258 (1939-09-01), Lederer
patent: 3582702 (1971-06-01), Almer
patent: 4164680 (1979-08-01), Villalobos
patent: 4428744 (1984-01-01), Edelson
patent: 4683889 (1987-08-01), Edelson
patent: 4848336 (1989-07-01), Fox et al.
patent: 4987007 (1991-01-01), Wagal et al.
patent: 4998930 (1991-03-01), Lundahl
patent: 5041108 (1991-08-01), Fox et al.
patent: 5059191 (1991-10-01), Beyer et al.
patent: 5090043 (1992-02-01), Parker et al.
patent: 5153900 (1992-10-01), Nomikos et al.
patent: 5334171 (1994-08-01), Kaldany
patent: 5405369 (1995-04-01), Selman et al.
patent: 5422926 (1995-06-01), Smith et al.
patent: 5566221 (1996-10-01), Smith et al.
patent: 5591199 (1997-01-01), Porter et al.
patent: 5621780 (1997-04-01), Smith et al.
patent: 5647840 (1997-07-01), D'Amelio et al.
patent: 5748699 (1998-05-01), Smith
patent: 5855595 (1999-01-01), Fujishima et al.
patent: 5871522 (1999-02-01), Sentilles
patent: 6061591 (2000-05-01), Freitag et al.
patent: 6070096 (2000-05-01), Hayashi
patent: 0 359 724 (1990-03-01), None
patent: 0 359 724 (1990-03-01), None
patent: 0 572 170 (1993-12-01), None
patent: 0 718 864 (1996-06-01), None
patent: 0 860 180 (1998-08-01), None
patent: 230 183 (1925-03-01), None
patent: 997 352 (1965-07-01), None
patent: WO 97/06549 (1997-02-01), None
patent: WO 97/07740 (1997-03-01), None
C.E. Millson et al., Ex-Vivo Treatment of Gastric Helicobacter Infection by Photodynamic Therapy; Journal of Photochemis
Harmon James V.
Shaver Kevin
Veniaminov Nikita R
LandOfFree
Apparatus and method for debilitating or killing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apparatus and method for debilitating or killing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apparatus and method for debilitating or killing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2944235